THE PRESSURE IS ON TO DIAGNOSE CHRONIC KIDNEY DISEASE (CKD)

AS FEW AS 10% OF ADULTS WITH CKD ARE DIAGNOSED, EVEN IN STAGE 31,2

Diagnose CKD
Diagnose CKD

THE PRESSURE IS ON TO DIAGNOSE CHRONIC KIDNEY DISEASE (CKD)

AS FEW AS 10% OF ADULTS WITH CKD ARE DIAGNOSED, EVEN IN STAGE 31,2

TAKE THE PRESSURE OFF BY FOLLOWING THESE THREE SIMPLE STEPS:

Diagnose early, check your patients eGFR values and kick off conversation with your patients.
Diagnose early, check your patients eGFR values and kick off conversation with your patients.

SEE WHY THE PRESSURE IS ON TO DIAGNOSE CKD IN ITS EARLIER STAGES

HIGH PREVALENCE
LOW DIAGNOSIS

CKD is a life-threatening disease that is vastly underdiagnosed.3

CKD affects an estimated 1 in 7 American adults.4

Only 1 in 10 American adults with stage 3 CKD are diagnosed
Only 1 in 10 American adults with stage 3 CKD are diagnosed

Only 1 in 10 American adults with Stage 3 CKD are diagnosed.1

Learn more about the importance of diagnosing CKD early.

CKD=chronic kidney disease; CV=cardiovascular; CVD=cardiovascular disease; eGFR=estimated glomerular filtration rate; GFR=glomerular filtration rate; HTN=hypertension; T2D=type 2 diabetes.

References:

  1. Ryan TP, Sloand JA, Winters PC, Corsetti JP, Fisher SG. Chronic kidney disease prevalence and rate of diagnosis. Am J Med. 2007;120(11):981-986.
  2. Ravera M, Noberasco G, Weiss U, et al. CKD awareness and blood pressure control in the primary care hypertensive population. Am J Kidney Dis. 2011;57(1):71-77.
  3. Chronic kidney disease basics. Centers for Disease Control and Prevention. Page reviewed February 7, 2020. Accessed February 9, 2021.
    https://www.cdc.gov/kidneydisease/basics.html
  4. Kidney Disease: The Basics. National Kidney Foundation. Published May 2020. Accessed February 9, 2021.
    https://www.kidney.org/news/newsroom/factsheets/KidneyDiseaseBasics
  5. Alabama Department of Public Health. Special Task Force on Chronic Kidney Disease report. April 2007. Accessed February 9, 2021.
    https://www.alabamapublichealth.gov/publications/assets/kidneydiseasereport.pdf
  6. Lewis EJ, Hunsicker LG, Clarke WR, et al; Collaborative Study Group. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345(12):851-860.
  7. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C-Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296-1305.
  8. Kidney disease statistics for the United States. National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Diseases. December 2016. Accessed February 9, 2021. https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease
  9. Schnaper HW. Remnant nephron physiology and the progression of chronic kidney disease. Pediatr Nephrol. 2014;29(2):193-202.
  10. Collard D, van Brussel PM, van de Velde L, et al. Estimation of intraglomerular pressure using invasive renal arterial pressure and flow velocity measurements in humans.J Am Soc Nephrol. 2020;31(8):1905-1914.